This article was originally published in The Rose Sheet
Executive SummaryFirm announces proposed underwritten public offering of 4,000,000 shares of its common stock, according to preliminary prospectus supplement to existing shelf registration statement filed Oct. 2 with the Securities & Exchange Commission. Offering will comprise 2,666,667 shares offered by Elizabeth Arden, in addition to 1,333,333 shares offered by Unilever, although company will not receive any of net proceeds from sale of Unilever shares. Arden says it will use net proceeds to redeem part of its 11 3/4% Senior Secured Notes due 2011...
You may also be interested in...
Lucky STAR: FDA’s eSTAR Pilot Aims To Make 510(k) Process Smoother With Submission Template For Device Makers
Nine manufacturers will soon have the chance to enroll in a voluntary eSTAR pilot program that the US agency says will make the premarket review process more efficient and consistent. The design and structure of an electronic Submission Template And Resource – or eSTAR – template is similar to templates used by FDA reviewers. An eSTAR won’t change the agency’s statutory or data requirements for sponsors to show substantial equivalence to predicate devices.
W3ll People is expected to add a relatively modest $7m to e.l.f. Beauty’s fiscal 2021 top line, but the brand has “major white space” opportunities, including at Target, e.l.f.’s longest-standing customer. Further, its plant-based product line includes 40 “EWG Verified” products, reflecting expertise e.l.f. is eager to tap.
UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.